Albrecht J, Szumanska G, Gadamski R, Gajkowska B
Department of Neuropathology, Medical Research Centre, Polish Academy of Sciences, Warsaw.
Neurotoxicology. 1994 Winter;15(4):897-902.
Inorganic mercury salts administered systemically at low mg/ml doses produce neurotoxic effects without penetrating the cerebral microvascular endothelial cells which form the blood-brain barrier (BBB). This phenomenon promoted investigations testing a hypothesis relating inorganic mercury-induced brain dysfunction to its interference with the BBB transport. In the present study, we tested the effect of a single i.p. administration of mercuric chloride (MC) (6 mg/kg body weight) on the activity and ultrastructural localization of cerebral alkaline phosphatase (AP), a cerebromicrovascular marker enzyme primarily located on luminal plasmalemma of endothelial cells. At 1h after MC administration, light microscopy revealed a virtual absence of AP in cerebral cortical layers II and III, and its dramatic reduction in the remaining layers. Electron microscopy confirmed the disappearance of the AP reaction product from luminal endothelial cell membranes, and luminal phasmalemma revealed pinocytic vesicles and invaginations likely to manifest changes in BBB transport. At 18h post-treatment, a moderate enzyme activity appeared on abluminal endothelial plasmalemma and on basement membrane, but remained absent from luminal plasmalemma. A similar picture persisted through day 5 post-treatment. The inhibition and subsequent translocation of AP activity from luminal to abluminal site and the accompanying ultrastructural changes are typical of the formation of "leaky" microvessels, previously reported for a variety of neuropathological conditions associated with BBB damage.
以低毫克/毫升剂量全身给药的无机汞盐会产生神经毒性作用,且不会穿透构成血脑屏障(BBB)的脑微血管内皮细胞。这一现象促使人们进行研究,以验证一个将无机汞诱导的脑功能障碍与其对血脑屏障转运的干扰联系起来的假说。在本研究中,我们测试了腹腔注射一次氯化汞(MC)(6毫克/千克体重)对脑碱性磷酸酶(AP)活性和超微结构定位的影响,AP是一种主要位于内皮细胞腔面膜上的脑微血管标记酶。腹腔注射氯化汞后1小时,光学显微镜检查显示大脑皮质II层和III层几乎没有AP,其余层中AP显著减少。电子显微镜证实了腔面内皮细胞膜上AP反应产物的消失,腔面膜显示有胞饮小泡和内陷,这可能表明血脑屏障转运发生了变化。治疗后18小时,在无腔面内皮细胞膜和基底膜上出现了适度的酶活性,但腔面膜上仍然没有。在治疗后第5天,情况仍然类似。AP活性从腔面到无腔面的抑制和随后的移位以及伴随的超微结构变化是“渗漏”微血管形成的典型表现,此前在与血脑屏障损伤相关的各种神经病理状况中已有报道。